GLOBE-NEWSWIRE

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

SINGAPORE, Dec. 07, 2025 (GLOBE NEWSWIRE) — Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions and an Oracle Partner, today announced it will offer connectivity to an Oracle Cloud Infrastructure (OCI) FastConnect point-of-presence (PoP) within the Oracle Cloud Singapore West

CGTN: China-Europe Ties: Shaping the Next 50 Years

CGTN: China-Europe Ties: Shaping the Next 50 Years BEIJING, Dec. 04, 2025 (GLOBE NEWSWIRE) — This year marks the 50th anniversary of the establishment of diplomatic relations between China and the European Union – a pivotal moment not only for reflecting on the past, but for exploring the pathway for